How Epstein-Barr Virus Affects B Cell Transformation
Author Information
Author(s): Nikitin Pavel A., Yan Christopher M., Forte Eleonora, Bocedi Alessio, Tourigny Jason P., White Robert E., Allday Martin J., Patel Amee, Dave Sandeep S., Kim William, Hu Katherine, Guo Jing, Tainter David, Rusyn Elena, Luftig Micah A.
Primary Institution: Duke University School of Medicine
Hypothesis
A robust innate tumor suppressor response is activated by latent viral oncoproteins and blocks outgrowth of the majority of infected cells.
Conclusion
The study identifies a molecular pathway that restricts Epstein-Barr virus transformation of B cells.
Supporting Evidence
- EBV infection activates a DNA damage response in primary B cells.
- The DDR is highest in rapidly proliferating B cells infected with EBV.
- ATM and Chk2 kinases suppress EBV B cell transformation early in infection.
- EBNA3C is required to attenuate the EBV-induced DNA damage response.
Takeaway
When the Epstein-Barr virus infects B cells, it causes them to grow quickly at first, but this rapid growth triggers a protective response that stops most of the cells from becoming cancerous.
Methodology
Primary human B cells were infected with Epstein-Barr virus and analyzed for DNA damage response activation and transformation efficiency.
Potential Biases
Potential bias in the selection of donor samples and the specific strains of EBV used.
Limitations
The study primarily focuses on in vitro findings, which may not fully represent in vivo conditions.
Participant Demographics
Five normal donors were used for the study.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website